Real World Evidence: Can We Really Expect It to Have Much Influence? Keith Evans Editorial Open access 23 April 2019 Pages: 43 - 45
A Benefit Risk Review of Pediatric Use of Hydrocodone/Chlorpheniramine, a Prescription Opioid Antitussive Agent for the Treatment of Cough Victor S. SloanAlphia JonesJürgen W. G. Bentz Review Article Open access 09 May 2019 Pages: 47 - 57
Adverse Events Associated with Risperidone Use in Pediatric Patients: A Retrospective Biobank Study Kazeem A. OshikoyaRobert CarrollSara L. Van Driest Original Research Article Open access 27 March 2019 Pages: 59 - 71
Prevalence of Psychotropic Polypharmacy and Associated Healthcare Resource Utilization during Initial Phase of Care among Adults with Cancer in USA Hilary A. ArokeAmi M. VyasStephen J. Kogut Original Research Article Open access 24 April 2019 Pages: 73 - 82
A Pilot Study to Assess the Feasibility of a Web-Based Survey to Examine Patient-Reported Symptoms and Satisfaction in Patients with Ankylosing Spondylitis Receiving Secukinumab Marina MagreyMichael BozyczkoYujin Park Original Research Article Open access 03 May 2019 Pages: 83 - 91
